Your browser does not support java script. Skip navigation
Loading, please wait  Loading, please wait...
 

SCSHP Fall Meeting 2023


October 3, 2023
Location:  Columbia Metropolitan Convention Center, 1101 Lincoln St. Columbia, SC 29201
 
To register, visit: https://scshp.com/meetinginfo.php
 
Fees:
  Pharmacist New Grad/Resident Technician Intern/Student
Member $160 $80 $80 $25
Non-Member $240 $160 $160 $80
 
To view ACPE Activity Announcement: Click here
 
To view the schedule of individual sessions as well as their learning objectives, please scroll to the bottom of the page. 
Clicking on the blue bars will expand the session details!

Date: Oct 3, 2023 08:00 AM - 05:00 PM

CE Hours

7.00

CE Units

0.700

Activity Type

  • Knowledge-Based and Application-Based

Target Audience(s)

  • Pharmacists
  • Pharmacy Technicians

Accreditation(s)

Accreditation Council for Pharmacy Education
The University of South Carolina College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Co-Sponsor(s)

South Carolina Society of Health-System Pharmacists (SCSHP)

Requirements for CE Credit

Participants must sign in upon arrival and have attendance verified.
 
To claim credit for this activity, participants must complete the online program evaluation and must update their accounts to properly reflect their month/day of birth and correct NABP e-Profile ID.  To register with NABP or look up your NABP e-Profile ID, please click on the CPE Monitor logo below to be directed to their site. 
 
Credit that is claimed greater than 60 days from the date of the program will be automatically rejected by the CPE Monitor.  Claiming credit within 30 days of the live program will ensure that any issues with transmission to the CPE Monitor can be rectified in advance of the 60-day deadline.  If you would like a paper statement of credit, you may print an individual statement or a transcript from your NABP e-Profile.
 
 

 

 

Registration closes on Dec 03, 2023 at 01:00 AM

Registration Closed  

At the completion of this activity, the pharmacist and pharmacy technician will be able to:
  1. Summarize the history and structure of the Practice Advancement Initiative 2030 (PAI 2030)
  2. Demonstrate how the results of ASHP National Survey and 2023 Pharmacy Forecast support the targets of practice change outlined in PAI 2030
  3. Illustrate published PAI 2030 best practice case studies
  4. Demonstrate the resources available from ASHP to our individual practitioners, organizations, and our state affiliate to develop action plans related to PAI 2030

Speaker(s)/Author(s)

Jennifer Bair, PharmD, BCPS
Vice President of Pharmacy Services and Chief Pharmacy Officer, Prisma Health; PGY1/2 HSPAL Residency Program Director, Prisma Health-Midlands – UofSC

Activity Number

0062-9999-23-139-L04-P/T
Date: 10/03/23
Time: 08:05 AM - 09:05 AM

CE Hours

1.00
 

Registration Closed  

At the completion of this activity, the pharmacist will be able to:
  1. Review the mechanism of action and approved indications for lecanemab, terlipressin, and Respiratory Syncytial Virus (RSV) vaccine and monoclonal antibody (mAb)
  2. Summarize lecanemab, terlipressin, and RSV vaccine and mAb place in therapy
  3. Describe health-system considerations for lecanemab, terlipressin, and RSV vaccine and mAb
 
At the completion of this activity, the pharmacy technician will be able to:
  1. Recall the approved indications for lecanemab, terlipressin, and RSV vaccines and mAb
  2. Recognize pharmacy and care areas where lecanemab, terlipressin, and RSV vaccine and mAb are provided
  3. Describe health-system considerations for lecanemab, terlipressin, and RSV vaccine and mAb

Speaker(s)/Author(s)

Sarah Harrison, PharmD, BCCCP
Pharmacy Executive Director, Vizient

Activity Number

0062-9999-23-140-L01-P/T
Date: 10/03/23
Time: 09:05 AM - 10:05 AM

CE Hours

1.00
 

Registration Closed  

At the completion of this activity, the pharmacist and pharmacy technician will be able to:
  1. Describe the epidemiology and pathophysiology of opioid use disorder (OUD)
  2. List current FDA approved medications for the treatment of OUD
  3. Discuss the pharmacology of buprenorphine
  4. Review alternatives to standard buprenorphine induction
  5. Apply acquired knowledge to a patient case
 

Speaker(s)/Author(s)

Sophie Robert, BPharm, PharmD, BCPP
Clinical Pharmacy Specialist in Psychiatry; Research Assistant Professor, Dept of Psychiatry & Behavioral Sciences; Adjunct Assistant Professor, MUSC College of Pharmacy, Medical University of South Carolina

Activity Number

0062-9999-23-141-L08-P/T
Date: 10/03/23
Time: 10:15 AM - 11:15 AM

CE Hours

1.00
 

Registration Closed  

At the completion of this activity, the pharmacist will be able to:
  1. Define the role of tele-antimicrobial stewardship as it applies to the Center for Diseases Control and Prevention (CDC) core elements of hospital stewardship
  2. Analyze current literature on tele-antimicrobial stewardship 
  3. Identify strategies associated with incorporating stewardship programs in regional sites’ workflow
  4. Develop action plans for expansion to regional sites given various examples
 
At the completion of this activity, the pharmacy technician will be able to:
  1. Outline the CDC core elements of tele-antimicrobial stewardship
  2. Discuss current literature regarding tele-antimicrobial stewardship
  3. Describe strategies associated with establishing antimicrobial stewardship in regional sites’ workflow
  4. Create action strategies to incorporate antimicrobial stewardship to regional sites given multiple examples
 

Speaker(s)/Author(s)

Aaron Hamby, PharmD, BCIDP
Clinical Pharmacy Specialist - Infectious Diseases, Medical University of South Carolina Health

Erin Brewer, PharmD, BCPS
Clinical Pharmacy Manager, MUSC Health Florence Medical Center

Activity Number

0062-9999-23-142-L04-P/T
Date: 10/03/23
Time: 11:15 AM - 12:15 PM

CE Hours

1.00
 

Registration Closed  

At the completion of this activity, the pharmacist and pharmacy technician will be able to:
  1. Describe pharmacist impact on commonly encountered clinical scenarios
  2. Provide an example of appropriate continuity of care for commonly encountered clinical scenarios
  3. Recognize medication safety principles in commonly encountered clinical scenarios
  4. Describe the importance of utilizing evidence-based medicine in commonly encountered clinical scenarios
 

Activity Number

0062-9999-23-143-L01-P/T
Date: 10/03/23
Time: 01:30 PM - 02:30 PM

CE Hours

1.00
 

Registration Closed  

At the completion of this activity, the pharmacist will be able to:
  1. Discuss the requirements of the South Carolina Pharmacy Access Act
  2. Compare the available hormonal contraception options including combined oral contraceptives, progestin only pill, rings, patches, and injections
  3. Apply the components of the Pharmacy Access Act to practice
  4. Determine an appropriate treatment option through a patient case
 
At the completion of this activity, the pharmacy technician will be able to:
  1. Discuss the requirements of the South Carolina Pharmacy Access Act
  2. Identify the available hormonal contraception options including combined oral contraceptives, progestin only pill, rings, patches, and injections
  3. Apply the components of the Pharmacy Access Act to a patient case

Speaker(s)/Author(s)

Marissa Pettit, PharmD
PGY1 Ambulatory Care Pharmacy Resident, Tandem Health-University of South Carolina College of Pharmacy

Activity Number

0062-9999-23-144-L03-P/T
Date: 10/03/23
Time: 02:40 PM - 03:40 PM

CE Hours

1.00
 

Registration Closed  

At the completion of this activity, the pharmacist will be able to:
  1. Describe important risk factors for cancer-associated thrombosis
  2. Predict which patients with cancer would benefit from prophylaxis for prevention of cancer-associated thrombosis
  3. Summarize recent guideline updates for the management of cancer-associated thrombosis
  4. Select an appropriate regimen for treatment of cancer-associated thrombosis
 
At the completion of this activity, the pharmacy technician will be able to:
  1. Discuss how the development of cancer-associated thrombosis may negatively affect prognosis
  2. List contraindications for use of prophylactic anticoagulation
  3. Compare and contrast medications used in the management of cancer-associated thrombosis

Speaker(s)/Author(s)

Andy Maldonado, PharmD
Assistant Professor, MUSC College of Pharmacy Clinical Pharmacy Specialist, Hematology-Oncology, MUSC Health

Activity Number

0062-9999-23-145-L01-P/T
Date: 10/03/23
Time: 03:55 PM - 04:55 PM

CE Hours

1.00